Premium
Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry
Author(s) -
Chartier Karen G.,
Sanchez Katherine,
Killeen Therese K.,
Burrow Allison,
Carmody Thomas,
Greer Tracy L.,
Trivedi Madhukar H.
Publication year - 2015
Publication title -
the american journal on addictions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.997
H-Index - 76
eISSN - 1521-0391
pISSN - 1055-0496
DOI - 10.1111/ajad.12190
Subject(s) - abstinence , stimulant , anxiety , psychiatry , psychology , clinical psychology , medicine
Background and Objectives Gender‐specific factors associated with stimulant abstinence severity were examined in a stimulant abusing or dependent residential treatment sample ( N = 302). Method Bivariate statistics tested gender differences in stimulant abstinence symptoms, measured by participant‐reported experiences of early withdrawal. Multivariate linear regression examined gender and other predictors of stimulant abstinence symptom severity. Results Women compared to men reported greater stimulant abstinence symptom severity. Anxiety disorders and individual anxiety‐related abstinence symptoms accounted for this difference. African American race/ethnicity was predictive of lower stimulant abstinence severity. Discussion and Conclusions Women were more sensitive to anxiety‐related stimulant withdrawal symptoms. Scientific Significance Clinics that address anxiety‐related abstinence symptoms, which more commonly occur in women, may improve treatment outcome. (Am J Addict 2015;XX:XX –XX)